Metride DS 4 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 4 mg and Metformin 1000 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and enhancing peripheral glucose uptake and utilization, contributing to improved insulin sensitivity. The synergistic action of these two agents helps achieve better blood glucose regulation compared to monotherapy. Metride DS 4 Tablet PR is typically prescribed when diet, exercise, and monotherapy with either agent fail to provide adequate glycemic control. It is essential to monitor blood glucose levels regularly and adjust the dosage based on therapeutic response and tolerability. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and hypoglycemia, particularly due to Glimepiride. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated in cases of diabetic ketoacidosis or severe renal dysfunction. Patient adherence to lifestyle modifications alongside medication is critical for optimal diabetes management with Metride DS 4 Tablet PR.

Dosage & How to Use